Yes, compared to tirzepatide, it could. Research shows tirzepatide often leads to a greater decrease in A1C than retatrutide.
Glucagon's job is to release stored glycogen as glucose, so retatrutide *can* potentially raise blood glucose, hence the higher A1C. However, many people on retatrutide...